TransDigm Group INC - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TransDigm Group Incorporated on December 9, 2011. The report discloses a material event occurring on the same date regarding the completion of a corporate acquisition.
Key Financial Metrics
The filing details a specific transaction value but does not provide comprehensive financial statements for the period.
- Acquisition Cost: Approximately $84 million in cash.
- Target Company: Harco Laboratories, Incorporated.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these metrics.
Material Changes
The primary material change is the completion of the acquisition of Harco Laboratories, Incorporated. This transaction was previously announced on November 8, 2011, and was finalized on December 9, 2011.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the disclosure of the acquisition itself. The transaction was executed in cash, which may impact liquidity, though specific post-transaction liquidity figures are not provided in this text.
Key Facts for Investor Verification
- Verify the exact cash consideration paid for Harco Laboratories, Incorporated ($84 million).
- Confirm the impact of this cash outflow on the company's current liquidity and debt levels in subsequent filings.
- Review the attached press release (Exhibit 99.1) for strategic rationale and integration plans.
- Monitor future 10-Q or 10-K filings for the financial contribution of Harco Laboratories to TransDigm's consolidated results.